2-amino-5-phosphonovalerate has been researched along with neostigmine in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chu, ZG; Hablitz, JJ; Zhou, FM | 1 |
Baxi, S; Evans, C; Irnaten, M; Mendelowitz, D; Venkatesan, P; Wang, J; Wang, X | 1 |
Decker, MW; Man, K; Parikh, V; Sarter, M | 1 |
3 other study(ies) available for 2-amino-5-phosphonovalerate and neostigmine
Article | Year |
---|---|
Nicotinic acetylcholine receptor-mediated synaptic potentials in rat neocortex.
Topics: 2-Amino-5-phosphonovalerate; 6-Cyano-7-nitroquinoxaline-2,3-dione; Acetylcholinesterase; Animals; Bicuculline; Dihydro-beta-Erythroidine; Excitatory Amino Acid Antagonists; Excitatory Postsynaptic Potentials; Kynurenic Acid; Mecamylamine; Neocortex; Neostigmine; Nicotinic Antagonists; Pyramidal Cells; Rats; Rats, Sprague-Dawley; Receptors, Nicotinic; Synaptic Transmission | 2000 |
Endogenous acetylcholine and nicotine activation enhances GABAergic and glycinergic inputs to cardiac vagal neurons.
Topics: 2-Amino-5-phosphonovalerate; Acetylcholine; Animals; Cholinesterase Inhibitors; Excitatory Amino Acid Antagonists; Excitatory Postsynaptic Potentials; Fluorescent Dyes; GABA Antagonists; gamma-Aminobutyric Acid; Glycine; Glycine Agents; Heart; Neostigmine; Neurons; Nicotine; Nicotinic Agonists; Parasympathetic Nervous System; Picrotoxin; Pyridazines; Rats; Strychnine; Synaptic Transmission; Vagus Nerve | 2003 |
Glutamatergic contributions to nicotinic acetylcholine receptor agonist-evoked cholinergic transients in the prefrontal cortex.
Topics: Acetylcholine; Analysis of Variance; Animals; Choline; Dihydro-beta-Erythroidine; Dose-Response Relationship, Drug; Electrochemistry; Evoked Potentials; Excitatory Amino Acid Antagonists; Glutamic Acid; In Vitro Techniques; Male; Mecamylamine; Neostigmine; Nicotine; Nicotinic Agonists; Nicotinic Antagonists; Prefrontal Cortex; Pyridines; Pyrrolidines; Quinoxalines; Rats; Sodium Channel Blockers; Tetrodotoxin; Valine | 2008 |